← All companies
INSP
Inspire Medical Systems, Inc.
$52.22
+2.20 +4.40%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.51B
Revenue (TTM)
$899M
Net income (TTM)
$135M
EPS (TTM)
$4.53
P/E ratio
11.5
Dividend yield
—
Free cash flow
$78.5M
Cash
$128M
Total assets
$926M
Gross margin
86.1%
52-week range
$38.91 – $147.03
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 3, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 3, 2026
8-K
Director or officer change
Jul 24, 2026
8-K
Director or officer change
Jul 22, 2026
8-K
Regulation FD disclosure
Jun 26, 2026
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results
May 5, 2026
10-Q
Quarter ended 2026-03-31
May 4, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 4, 2026
10-K
Fiscal year ended 2025-12-31
Feb 13, 2026
8-K
Results of operations (earnings release); Amended charter or bylaws; Regulation FD disclosure
Feb 11, 2026
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Jan 12, 2026
8-K
Other events
Nov 17, 2025
10-Q
Quarter ended 2025-09-30
Nov 3, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 3, 2025
8-K
Regulation FD disclosure
Oct 10, 2025
8-K
Director or officer change; Regulation FD disclosure
Aug 26, 2025
8-K
Other events
Aug 11, 2025
10-Q
Quarter ended 2025-06-30
Aug 4, 2025
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Aug 4, 2025
8-K
Regulation FD disclosure
Jun 13, 2025
10-Q
Quarter ended 2025-03-31
May 5, 2025
8-K
Shareholder vote results
May 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 5, 2025
10-K
Fiscal year ended 2024-12-31
Feb 10, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 10, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2025
8-K
Other events
Nov 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 4, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 4, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Aug 6, 2024
8-K
Other events
Aug 2, 2024
8-K
Results of operations (earnings release)
Jul 29, 2024
8-K
Director or officer change
Jul 22, 2024
8-K
Shareholder vote results
May 7, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2024
10-K
Fiscal year ended 2023-12-31
Feb 9, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 6, 2024
8-K
Director or officer change
Feb 5, 2024